Virginia Retirement Systems Et Al Fibrogen Inc Transaction History

Virginia Retirement Systems Et Al

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 21, 2022	SELL	$12.02 - $16.79 $120,200 - $167,900	-10,000 Closed	0 $0
Q4 2021 Feb 03, 2022	BUY	$9.93 - $15.39 $99,300 - $153,900	10,000 New	10,000 $141,000
Q3 2020 Nov 12, 2020	SELL	$40.47 - $45.5 $530,157 - $596,050	-13,100 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$32.57 - $42.83 $65,140 - $85,660	-2,000 Reduced 13.25%	13,100 $531,000
Q4 2019 Jan 27, 2020	BUY	$34.58 - $48.06 $522,158 - $725,706	15,100 New	15,100 $648,000

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

Stay updated on Virginia Retirement Systems Et Al with notifications on news.